v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 551,403 $ 585,972
Adjustments to reconcile net income to cash (used in) provided by operating activities:    
Depreciation, amortization and accretion 250,523 187,921
Share-based compensation 9,394 15,191
Deferred income taxes 5,861 (58,399)
Gain on sales of businesses, net 0 (1,115)
Other, net 7,171 1,650
Changes in operating assets and liabilities:    
Accounts receivable, trade (417,136) 29,613
Inventories (323,781) (215,493)
Government grants receivable (177,419) 205,528
Other assets (106,090) (168,363)
Income tax receivable and payable (39,698) 3,774
Accounts payable and accrued expenses (85,119) (113,255)
Deferred revenue (186,652) (12,499)
Other liabilities 53,138 212
Net cash (used in) provided by operating activities (458,405) 460,737
Cash flows from investing activities:    
Purchases of property, plant and equipment (494,100) (778,618)
Purchases of marketable securities and restricted marketable securities (930,807) (1,113,826)
Proceeds from maturities of marketable securities 1,067,702 1,224,167
Other investing activities 7,002 (7,697)
Net cash used in investing activities (350,203) (675,974)
Cash flows from financing activities:    
Proceeds from borrowings under debt arrangements, net of issuance costs 212,273 110,395
Repayment of Debt (244,022) (111,375)
Proceeds from other borrowings 394,450 0
Payments of tax withholdings for restricted shares (15,436) (19,148)
Contingent consideration payment and other financing activities (266) (7,527)
Net cash provided by (used in) financing activities 346,999 (27,655)
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents 3,469 (5,600)
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents (458,140) (248,492)
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of the period 1,638,223 1,965,069
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of the period 1,180,083 1,716,577
Supplemental disclosure of noncash investing and financing activities:    
Property, plant and equipment acquisitions funded by liabilities 242,177 402,263
Proceeds to be received from asset-based government grants 155,336 158,908
Acquisitions funded by contingent consideration $ 3,600 $ 11,000